Eton Pharmaceuticals, Inc. (ETON) financial statements (2021 and earlier)

Company profile

Business Address 21925 W. FIELD PARKWAY
DEER PARK, IL 60010-7208
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1227
Cash and cash equivalents1227
Receivables0 
Inventory, net of allowances, customer advances and progress billings0 
Inventory0 
Prepaid expense 1
Other undisclosed current assets2 
Total current assets:1528
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment11
Intangible assets, net (including goodwill)1 
Intangible assets, net (excluding goodwill)1 
Other noncurrent assets00
Total noncurrent assets:21
TOTAL ASSETS:1728
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22
Accounts payable11
Accrued liabilities11
Total current liabilities:22
Noncurrent Liabilities
Long-term debt and lease obligation0 
Operating lease, liability0
Other undisclosed noncurrent liabilities5 
Total noncurrent liabilities:5 
Total liabilities:72
Stockholders' equity
Stockholders' equity attributable to parent1126
Common stock00
Additional paid in capital7572
Accumulated deficit(64)(46)
Total stockholders' equity:1126
TOTAL LIABILITIES AND EQUITY:1728

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Revenues1 
Cost of revenue
(Cost of Goods and Services Sold)
(0) 
Gross profit:1 
Operating expenses(19)(10)
Operating loss:(19)(10)
Loss from continuing operations before equity method investments, income taxes:(19)(10)
Other undisclosed income (loss) from continuing operations before income taxes0(2)
Loss from continuing operations before income taxes:(18)(13)
Income tax expense (3)
Loss before gain (loss) on sale of properties:(18)(15)
Other undisclosed net income 3
Net loss attributable to parent:(18)(13)
Other undisclosed net loss available to common stockholders, basic (24)
Net loss available to common stockholders, diluted:(18)(37)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(18)(13)
Comprehensive loss, net of tax, attributable to parent:(18)(13)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: